Press release
Global Drug Eluting Balloon Catheter Market Report by Manufacturers, Types, Regions and Application Research Report Forecast to 2022
Fact.MR
Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=146
Drug-eluting balloon (DEB), also known as drug-coated balloon (DCB) is one of the newest medical devices under the catheter segment. Drug-eluting balloon catheter is used in undertaking peripheral artery procedures, particularly to reduce the rate of restenosis. A drug-eluting balloon catheter is inserted into a narrowed, unhealthy coronary or peripheral artery that slowly releases a drug to restrict further cell proliferation.
Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive
Europe is currently the largest market for drug eluting balloon catheter and is expected to continue its dominance throughout the assessment period. The market in the region is set to reflect a robust CAGR of 20.5% during the assessment period. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) will reflect the fastest CAGR and gain 452 BPS between 2017 and 2022.
By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.
By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.
Competition Tracking
Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.
Browse Full Report with TOC@ https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market
Table of Contents:
Global Drug Eluting Balloon Catheter Market – Executive Summary
Global Drug Eluting Balloon Catheter Market Overview
2.1. Introduction
2.1.1. Global Drug Eluting Balloon Catheter Market Taxonomy
2.1.2. Global Drug Eluting Balloon Catheter Market Definition
2.2. Global Drug Eluting Balloon Catheter Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Drug Eluting Balloon Catheter Market Y-o-Y Growth
2.3. Global Drug Eluting Balloon Catheter Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. Product Mapping Behavior By Region
2.7. Average Pricing Analysis
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Drug Eluting Balloon Catheter Market Analysis and Forecast By Indication
3.1. Global Drug Eluting Balloon Catheter Market Size and Forecast By Indication, 2012-2022
3.1.1. Coronary Artery Disease Drug Eluting Balloon Catheter Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
Continued………..
Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=146
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Drug Eluting Balloon Catheter Market Report by Manufacturers, Types, Regions and Application Research Report Forecast to 2022 here
News-ID: 1034892 • Views: …
More Releases from Fact.MR
European Permanent Magnets Industry Analysis in the USA Outlook 2025-2035: Key D …
The United States permanent magnets industry is projected to expand from an estimated US$ 5.28 billion in 2025 to approximately US$ 9.01 billion by 2035, achieving a steady CAGR of about 5.5% over the forecast decade. High-performance magnet types-especially neodymium-iron-boron (NdFeB)-are expected to remain the dominant material, accounting for roughly half of all U.S. demand in 2025. The automotive sector, led by electric vehicle (EV) growth, is forecast to retain…
European Nutraceutical Packaging Market Outlook 2025-2035: Key Developments and …
The European nutraceutical packaging market is forecast to grow robustly from an estimated US$ 1.4 billion in 2025 to nearly US$ 2.3 billion by 2035, expanding at a projected CAGR of approximately 4.8%. Strong supplement consumption, eco-friendly packaging investments, and advanced production technologies are expected to be the primary catalysts for this decade-long expansion.
As Europe's population becomes increasingly health-conscious and preventive healthcare gains widespread traction, demand for vitamins, minerals, herbal…
European Fluorosurfactant Market Outlook 2025-2035: Key Developments and Future …
The European fluorosurfactant market is projected to experience strong growth between 2025 and 2035 - nearly doubling in value over the decade. This uptrend is being driven by rising demand from high-performance coatings, adhesives, electronics, and industrial sectors, coupled with increasing pressure to develop more environmentally sustainable fluorinated surfactants.
Key Growth Drivers
High-Performance Applications:
Fluorosurfactants are prized for their exceptional wetting, levelling, and low surface tension properties, making them indispensable in specialty coatings,…
European Cell Culture Vessels Market Outlook 2025-2035: Key Developments and Fut …
The European cell culture vessels market is poised for robust growth between 2025 and 2035, driven by a sharp uptick in biopharmaceutical research, the growing popularity of single-use systems, and increasing regulatory momentum around advanced therapies.
By 2030, the European cell culture vessels market could reach over US$ 3 billion, underpinned by a projected compound annual growth rate (CAGR) in double digits. This trajectory underscores how critical innovative cell culture platforms…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
